Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Sell
24
VNDA Quote, Financials, Valuation and Earnings
Last price:
$4.86
Seasonality move
:
-4.37%
Day range:
$4.77 - $4.89
52-week range:
$3.46 - $6.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.46x
P/B ratio:
0.52x
Volume:
510.4K
Avg. volume:
616.7K
1-year change:
14.32%
Market cap:
$279.3M
Revenue:
$192.6M
EPS (TTM):
-$0.28
Earnings Data
Next earnings date for VNDA
Feb 07
2025
Most recent earnings per share
-$0.09
Missed by $0.09
(Nov 6/2024)
Consensus Estimate
--
(Nov 6/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
VNDA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2025 | Q1 | $61M | -- | -- | -- | -- |
| 02/07/2025 | Q4 | $52.2M | -- | -- | -- | -- |
| 11/06/2024 | Q3 | $49.2M | $47.7M | -$0.09 | -- | -- |
| 07/31/2024 | Q2 | $47.9M | $50.5M | -$0.08 | -- | -- |
| 05/08/2024 | Q1 | -- | $47.5M | -$0.07 | -- | -- |
| 02/07/2024 | Q4 | $37M | $45.3M | -$0.04 | -- | -- |
| 11/08/2023 | Q3 | -- | -- | $0.00 | -- | -- |
| 07/27/2023 | Q2 | -- | -- | $0.03 | -- | -- |
| 05/03/2023 | Q1 | -- | -- | $0.06 | -- | -- |
| 02/08/2023 | Q4 | -- | -- | $0.12 | -- | -- |
| 11/02/2022 | Q3 | -- | -- | $0.06 | -- | -- |
| 08/03/2022 | Q2 | -- | -- | $0.05 | -- | -- |
| 05/05/2022 | Q1 | -- | -- | -$0.11 | -$0.01 | -$0.10 |
| 02/23/2022 | Q4 | -- | -- | $0.12 | $0.09 | $0.04 |
| 11/03/2021 | Q3 | -- | -- | $0.14 | $0.18 | -$0.04 |
| 07/28/2021 | Q2 | -- | -- | $0.17 | $0.11 | $0.06 |
| 05/05/2021 | Q1 | -- | -- | $0.15 | -- | -- |
| 02/10/2021 | Q4 | -- | -- | $0.14 | -- | -- |
| 10/28/2020 | Q3 | -- | -- | $0.11 | -- | -- |
| 08/05/2020 | Q2 | -- | -- | $0.16 | -- | -- |
| 05/06/2020 | Q1 | -- | -- | $0.01 | $0.01 | -- |
| 02/25/2020 | Q4 | -- | -- | $0.08 | $0.25 | -$0.17 |
| 11/06/2019 | Q3 | -- | -- | $1.84 | $0.07 | $1.77 |
| 07/31/2019 | Q2 | -- | -- | $0.28 | $0.05 | $0.23 |
| 05/01/2019 | Q1 | -- | -- | $0.06 | $0.07 | -$0.01 |
| 02/13/2019 | Q4 | -- | -- | $0.26 | $0.13 | $0.14 |
| 11/07/2018 | Q3 | -- | -- | $0.20 | $0.01 | $0.19 |
| 08/01/2018 | Q2 | -- | -- | $0.14 | $0.02 | $0.12 |
| 05/02/2018 | Q1 | -- | -- | $0.14 | -$0.04 | $0.18 |
| 02/14/2018 | Q4 | -- | -- | $0.03 | -$0.06 | $0.09 |
| 11/07/2017 | Q3 | -- | -- | -$0.03 | -$0.05 | $0.02 |
| 08/02/2017 | Q2 | -- | -- | $0.03 | -$0.20 | $0.23 |
| 05/02/2017 | Q1 | -- | -- | -$0.11 | -$0.14 | $0.03 |
| 02/15/2017 | Q4 | -- | -- | -$0.01 | -$0.13 | $0.12 |
| 11/02/2016 | Q3 | -- | -- | $0.06 | -- | -- |
| 07/27/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/04/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/10/2016 | Q4 | -- | -- | -- | -- | -- |
| 11/03/2015 | Q3 | -- | -- | -- | -- | -- |
| 07/29/2015 | Q2 | -- | -- | -- | -- | -- |
| 05/06/2015 | Q1 | -- | -- | -- | -- | -- |
Vanda Pharmaceuticals Earnings Questions
-
How Much did Vanda Pharmaceuticals Generate in Revenue Last Quarter?
Vanda Pharmaceuticals reported $47.7M worth of top line sales in its most recent quarter.
-
Did Vanda Pharmaceuticals Beat Earnings Last Quarter?
Vanda Pharmaceuticals announced earnings per share of -$0.09 which represents a miss of analyst forecast a -- per share.
-
Is Vanda Pharmaceuticals Profitable?
Vanda Pharmaceuticals reported $45.1M that represents $0.77 per share over the last quarter.
-
What is the Analyst Consensus for Vanda Pharmaceuticals EPS Next Year?
Vanda Pharmaceuticals's earnings are forecast to grow from $0.04 per share to -- per share next year representing an increase of --.
-
When is Vanda Pharmaceuticals's Earnings Date?
Vanda Pharmaceuticals's next earnings date is February 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 22.25% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is down 10.89% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is down 3.89% over the past day.
